Analysis
Refine Search
Pharmaceutical
Big things are happening in oncology at the moment. Considering all stages of clinical development, there are thought to be up to 8,000 anticancer candidates be 12 November 2018
Pharmaceutical
For the era of personalized therapies to truly arrive, industry observers often express the view that pharma will have to improve its understanding not just of 30 October 2018
Pharmaceutical
Russia’s arrival as a major player in the digitalization of healthcare was abundantly clear at a Moscow event held to celebrate and stimulate advances in the se 25 October 2018
Pharmaceutical
Something like 20,000 conference delegates are gathered in Munich for the start of what promises to be another important meeting of the European Society of Medi 19 October 2018
Pharmaceutical
Previous scandals and improvements in standards and transparency mean that the conversations and exchanges of information that take place between pharmaceutical 12 October 2018
Biotechnology
At EASD 2018, The Pharma Letter spoke with Novo Nordisk’s (NOV: N) chief medical officer Stephen Gough and chief science officer Mads Krogsgaard Thomsen and abo 2 October 2018
Pharmaceutical
In the age of spiralling research and development costs and the pressure to minimise risk and maximise reward in bringing new drugs to market. 12 September 2018
Pharmaceutical
US President Donald Trump’s recently initiated trade war with China has divided opinion between those who see it as a potentially industry-damaging misstep, and 4 September 2018
Pharmaceutical
“The Russian pharma market is like a huge ocean. If you know who lives in the ocean and what sort of currents the ocean has, then it is all simple and understan 10 August 2018
article
No need for anxiety — that’s the line at the launch of a new white paper from contract research organization IQVIA, tackling the uncertainty facing UK biopharma 7 August 2018
Biotechnology
Strictly speaking.the modern biotech industry can be dated to the discovery of penicillin.first synthesized by Alexander Fleming in 1928.but it’s not until the 27 July 2018
Pharmaceutical
The growth of privately-held Swiss drugmaker Ferring Pharmaceuticals in the US market has been nothing short of remarkable. 14 July 2018
Generics
Like other victims of a toxic US political environment, Obama-era FDA pick Robert Califf did not long survive the political turbulence of presidential election 11 July 2018
Pharmaceutical
Conference attendees gathered in the cavernous RAI Amsterdam convention center last week to hear the latest data from a therapy area valued at around $44 billio 22 June 2018
Biotechnology
Experts from the International Society for Cell and Gene Therapy (ISCT) told The Pharma Letter last month that the last 12 months had been the most important ye 10 June 2018
Pharmaceutical
This week, cancer patients, oncologists and investors alike look ahead to the annual meeting of the American Society of Clinical Oncology (ASCO), which kicks of 29 May 2018
Pharmaceutical
A report concludes that the prospect of leaving the European Union (EU) without an agreement that protects the UK’s pharmaceutical industry would be disastrous 17 May 2018
Pharmaceutical
The progress achieved in treating huge swathes of the world’s HIV-infected population in the last 20 to 30 years might give the impression of a therapy area whe 8 May 2018
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze